MANTOVANI, LORENZO
MANTOVANI, LORENZO
DIPARTIMENTO DI SCIENZE FARMACOLOGICHE (attivo dal 01/01/2001 al 27/04/2012)
Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases
2020 M. Viganò, L. Mantovani, M. Cozzolino, A. Harari
Health related quality of life in scleroderma patients treated with two different intravenous iloprost regimens
2018 T. Schioppo, L. Scalone, P. Cozzolino, L. Mantovani, G. Cesana, O. DE LUCIA, A. Murgo, F. Ingegnoli
Optimising the clinical strategy for autoimmune liver diseases : Principles of value-based medicine
2018 M. Carbone, L. Cristoferi, P.A. Cortesi, M. Rota, A. Ciaccio, S. Okolicsanyi, M. Gemma, L. Scalone, G. Cesana, L. Fabris, M. Colledan, S. Fagiuoli, G. Ideo, L.S. Belli, L.M. Munari, L. Mantovani, M. Strazzabosco
The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B : a systematic review and network meta-analysis
2014 S. Mealing, I. Ghement, N. Hawkins, D.A. Scott, B. Lescrauwaet, M. Watt, M. Thursz, P. Lampertico, L. Mantovani, E. Morais, B. Bregman, M. Cucherat
Haemophilia prophylaxis : how can we justify the costs?
2012 B.M. Feldman, K. Berger, R. Bohn, M. Carcao, K. Fischer, A. Gringeri, K. Hoots, L. Mantovani, A.R. Willian, W. Schramm
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
2011 A. Gringeri, B. Lundin, S. von Mackensen, L. Mantovani, P.M. Mannucci, E. Study Group
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors
2011 C. Leissinger, A. Gringeri, B. Antmen, E. Berntorp, C. Biasoli, S. Carpenter, P. Cortesi, H. Jo, K. Kavakli, R. Lassila, M. Morfini, C. Négrier, A. Rocino, W. Schramm, M. Serban, M.V. Uscatescu, J. Windyga, B. Zülfikar, L. Mantovani
A randomized clinical trial on prophylaxis vs. episodic treatment in children with haemophilia A : the ESPRIT study
2010 A. Gringeri, B. Lundin, S. Von Mackensen, L. Mantovani, P.M. Mannucci
The european study of clinical, health economic and quality of life outcomes in 1426 haemophilia patients
2009 W. Schramm, K. Berger, B. Bullinger, A. Crispin, P. Giangrande, A. Giebl, A. Gringeri, R. Ljung, L. Nemes, S.V. Mackensen, L. Mantovani, M. Serban
Primary and secondary prophylaxis in children with haemophilia A reduces bleeding frequency and arthropathy development compared to on-demand treatment : a 10-year, randomized, clinical trial
2009 A. Gringeri, B. Lundin, S. Von Mackensen, L. Mantovani, P.M. Mannucci
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors : results from the COHIBA Study
2009 L. Scalone, L. Mantovani, F. Borghetti, S. Von Mackensen, A. Gringeri
Resource consumption in haemophilia care – the ESCHQoL study (European study of clinical, health economic and quality of life outcomes in haemophilia treatment)
2009 K. Berger, M. Bullinger, P. Giangrande, A. Giebl, A. Gringeri, R. Ljung, L. Nemes, S. Von Mackensen, L. Mantovani, M. Serban, M. Shlaen, W. Schramm
A 10-year, randomized, clinical trial on prophylaxis vs. on-demand treatment in children with haemophilia A : the E.S.P.R.I.T. study
2008 A. Gringeri, B. Lundin, S. von Mackensen, L. Mantovani, P.M. Mannucci
Preferences towards the characteristics of coagulation factor concentrates used to treat hemophilic patients with inhibitors : the patients', physicians' and pharmacists' perspective
2008 A. Gringeri, F. Borghetti, L. Scalone, S. von Mackensen, L. Mantovani
Prospective cost-effectiveness study of regular continuous prophylactic replacement therapy in adults with severe hemophilia A
2008 A. Gringeri, M.S. Monzini, S. von Mackensen, M. Muça-Perja, F. Borghetti, L. Mantovani
Cost, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy : the ITHACA study
2008 L. Scalone, L. Mantovani, M. Krol, D. Rofail, S. Ravera, M.G. Bisconte, C. Borgna Pignatti, Z. Borsellino, P. Cianciulli, D. Gallisai, L. Prossomariti, S. Ippazio, M.D. Cappellini
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
2006 L. SCALONE, L. G. MANTOVANI, P. M. MANNUCCI, A. GRINGERI, THE COCIS STUDY INVESTIGATORS
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA
2006 Francesca Rossetti, Simona De Portu, Enrica Menditto, Luciana Scalone, Silvia Bustacchini, Claudio Cricelli, Lorenzo Giovanni Mantovani
The pharmacoeconomic impact of amlodipine use on coronary artery disease
2006 Simona De Portu, Enrica Menditto, Luciana Scalone, Silvia Bustacchini, Claudio Cricelli, Lorenzo Giovanni Mantovani
Quality of life in hemophilic patients without inhibitors : the COCHE study
2005 L. Scalone, A. Gringeri, S. Von Mackensen, P.M. Mannucci, S. De Silvo, M. Anastasia, F. DI STASI, L.G. Mantovani